Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

AdaptHealth (AHCO) Revenue (2019 - 2026)

AdaptHealth has reported Revenue over the past 7 years, most recently at $846.3 million for Q4 2025.

  • For Q4 2025, Revenue fell 1.21% year-over-year to $846.3 million; the TTM value through Dec 2025 reached $3.2 billion, changed 0.49%, while the annual FY2025 figure was $3.2 billion, 0.49% changed from the prior year.
  • Revenue for Q4 2025 was $846.3 million at AdaptHealth, up from $820.3 million in the prior quarter.
  • Over five years, Revenue peaked at $858.2 million in Q4 2023 and troughed at $482.1 million in Q1 2021.
  • A 5-year average of $756.6 million and a median of $786.4 million in 2022 define the central range for Revenue.
  • Biggest five-year swings in Revenue: soared 165.82% in 2021 and later dropped 1.84% in 2025.
  • Year by year, Revenue stood at $702.1 million in 2021, then rose by 11.13% to $780.3 million in 2022, then rose by 9.99% to $858.2 million in 2023, then fell by 0.19% to $856.6 million in 2024, then decreased by 1.21% to $846.3 million in 2025.
  • Business Quant data shows Revenue for AHCO at $846.3 million in Q4 2025, $820.3 million in Q3 2025, and $800.4 million in Q2 2025.